MARKET

CORT

CORT

Corcept Therapeutics Inc
NASDAQ
52.28
+1.23
+2.41%
Pre Market: 51.76 -0.52 -0.99% 04:07 05/11 EDT
OPEN
51.05
PREV CLOSE
51.05
HIGH
52.48
LOW
50.32
VOLUME
11
TURNOVER
0
52 WEEK HIGH
91.00
52 WEEK LOW
28.66
MARKET CAP
5.61B
P/E (TTM)
147.39
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CORT last week (0504-0508)?
Weekly Report · 42m ago
Corcept CEO Joseph Belanoff disposes 40,000 shares worth $2 million
PUBT · 5d ago
Corcept Therapeutics Signals Big Growth After Key Wins
TipRanks · 6d ago
Corcept: 'Strong Buy' On Lifyorli FDA Approval And ALS Phase 3 Advancement
Seeking Alpha · 6d ago
Packaging Corp Of America To Rally More Than 17%? Here Are 10 Top Analyst Forecasts For Monday
Benzinga · 6d ago
Canaccord Genuity Remains a Buy on Corcept Therapeutics (CORT)
TipRanks · 6d ago
Corcept Therapeutics Price Target Raised to $75.00/Share From $60.00 by HC Wainwright & Co.
Dow Jones · 6d ago
Corcept Therapeutics Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 6d ago
More
About CORT
Corcept Therapeutics Incorporated is a commercial-stage company. The Company is engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol. The Company operates through the discovery, development and commercialization of the pharmaceutical products segment. The Company has marketed Korlym (mifepristone) in the United States for the treatment of patients suffering from Cushings syndrome. The Company’s portfolio of selective cortisol modulators consists of four series totaling approximately 1,000 compounds. Its portfolio of selective cortisol modulators consists of relacorilant, dazucorilant and miricorilant. Korlyms active ingredient, mifepristone, reduces the binding of excess cortisol to the GR, it can modulate the effects of abnormal levels and release patterns of cortisol without compromising cortisols healthy functions and rhythms.

Webull offers Corcept Therapeutics Inc stock information, including NASDAQ: CORT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CORT stock methods without spending real money on the virtual paper trading platform.